Oncohematology and Genetics

Biology of hematological processes

Ildefonso Espigado Tocino
Ildefonso Espigado Tocino

Ildefonso Espigado Tocino

Back to program
  1. Group members
  2. Research areas
  3. Publications

Group: Biology of hematological processes

Directory
Foto no disponible
  • Espigado Tocino, Ildefonso.Doctor en Medicina y Cirugía
  • Limón Ramos, Carmen.Diplomada en Enfermería
  • Reinoso Segura, Marta.Diplomada en Enfermería
  • Rodríguez Torres, Nancy.Lda. en Medicina y Cirugía

Research areas

International Journals
Solano, C; Vazquez, L; Gimenez, E; de la Camara, R; Albert, E; Rovira, M; Espigado, I; Calvo, CM; Lopez-Jimenez, J; Suarez-Lledo, M; Chinea, A; Esquirol, A; Perez, A; Bermudez, A; Saldana, R; Heras, I; Gonzalez-Huerta, AJ; Torrado, T; Batlle, M; Jimenez, S; Vallejo, C; Barba, P; Cuesta, MA; Pinana, JL; Navarro, D
Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment
BONE MARROW TRANSPLANTATION
Pinana, JL; Martino, R; Garcia-Garcia, I; Parody, R; Morales, MD; Benzo, G; Gomez-Catalan, I; Coll, R; De la Fuente, I; Luna, A; Merchan, B; Chinea, A; de Miguel, D; Serrano, A; Perez, C; Diaz, C; Lopez, JL; Saez, AJ; Bailen, R; Zudaire, T; Martinez, D; Jurado, M; Calbacho, M; Vazquez, L; Garcia-Cadenas, I; Fox, L; Pimentel, AI; Bautista, G; Nieto, A; Fernandez, P; Vallejo, JC; Solano, C; Valero, M; Espigado, I; Saldana, R; Sisinni, L; Ribera, JM; Jimenez, MJ; Trabazo, M; Gonzalez-Vicent, M; Fernandez, N; Talarn, C; Montoya, MC; Cedillo, A; Sureda, A
Risk factors and outcome of COVID-19 in patients with hematological malignancies
EXPERIMENTAL HEMATOLOGY & ONCOLOGY
Burillo-Sanz S, Morales-Camacho RM, Caballero-Velázquez T, Carrillo E, Sánchez J, Pérez-López O, Pérez de Soto I, González Campos J, Prats-Martín C, Bernal R, Vargas MT.
MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression.
Eur J Haematol.
Falantes JF, Márquez-Malaver FJ, Calderón-Cabrera C, Pedrote B, Martino ML, González J, Espigado I, Pérez-Simón JA.
Evaluation of Parameters Related to the Probability of Leukemic Progression in Patients With Lower-Risk Myelodysplastic Syndrome.
Clin Lymphoma Myeloma Leuk.
Martínez-Laperche C, Buces E, Aguilera-Morillo MC, Picornell A, González-Rivera M, Lillo R, Santos N, Martín-Antonio B, Guillem V, Nieto JB, González M, de la Cámara R, Brunet S, Jiménez-Velasco A, Espigado I, Vallejo C, Sampol A, Bellón JM, Serrano D, Kwon M, Gayoso J, Balsalobre P, Urbano-Izpizua Á, Solano C, Gallardo D, Díez-Martín JL, Romo J, Buño I, GVHD/Immunotherapy Committee of the Spanish Group for Hematopoietic Transplantation.
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms.
Blood Adv.
Medrano M, Carrillo-Cruz E, Montero I, Pérez-Simón JA.
Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications.
Int J Mol Sci.
Pardal E, Díez Baeza E, Salas Q, García T, Sancho JM, Monzón E, Moraleda JM, Córdoba R, de la Cruz F, Queizán JA, Rodríguez MJ, Navarro B, Hernández JA, Díez R, Vahi M, Viguria MC, Canales M, Peñarrubia MJ, González-López TJ, Montes-Moreno S, González-Barca E, Caballero D, Martín A, GELTAMO Spanish Collaborative Group.
A new prognostic model identifies patients aged 80 years and older with diffuse large B-cell lymphoma who may benefit from curative treatment: A multicenter, retrospective analysis by the Spanish GELTAMO group
Am J Hematol.
Prats-Martín C, Jiménez-Guerrero P, Morales-Camacho RM, Caballero-Velázquez T, Vargas MT, Pérez O, Montero I, Falantes J, Burillo-Sanz S, Carrillo E, Borrero JJ, Bernal R, Pérez-Simón JA.
KIT D816V- chronic myelomonocytic leukemia progressing to KIT D816V+ associated to mast cell leukemia responding to allogeneic hematopoietic cell transplantation.
Ann Hematol.
Aguilar-Guisado M, Espigado I, Martín-Peña A, Gudiol C, Royo-Cebrecos C, Falantes J, Vázquez-López L, Montero MI, Rosso-Fernández C, de la Luz Martino M, Parody R, González-Campos J, Garzón-López S, Calderón-Cabrera C, Barba P, Rodríguez N, Rovira M, Montero-Mateos E, Carratalá J, Pérez-Simón JA, Cisneros JM.
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial.
Lancet Haematol.
Chen-Liang TH, Martín-Santos T, Jerez A, Rodríguez-García G, Senent L, Martínez-Millán C, Muiña B, Orero M, Teruel A, Martín A, Gómez-Espuch J, Kennedy K, Benet C, Raya JM, Fernández-González M, de la Cruz F, Guinot M, Villegas C, Ballester I, Baile M, Moya M, López-Jiménez J, Frutos L, Navarro JL, Uña J, Fernández-López R, Igua C, Contreras J, Sánchez-Vañó R, Cózar MDP, Tamayo P, Mucientes J, Sánchez-Blanco JJ, Pérez-Ceballos E, Ortuño FJ.
Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma.
Cancer Med.
de-Bonilla-Damiá Á, Fernández-López R, Capote-Huelva FJ, de la Cruz-Vicente F, Egea-Guerrero JJ, Borrego-Dorado I.
Role of 18F-FDG PET/CT in primary brain lymphoma.
Rev Esp Med Nucl Imagen Mol.
Falantes JF, Márquez-Malaver FJ, Knight T, Calderón-Cabrera C, Martino ML, González J, Montero I, Espigado I, Pérez-Simón JA.
de-Bonilla-Damiá Á, Fernández-López R, Capote-Huelva FJ, de la Cruz-Vicente F, Egea-Guerrero JJ, Borrego-Dorado I. Rev Esp Med Nucl Imagen Mol.
Leuk Lymphoma.
Jurado M, De La Mata C, Ruiz-García A, López-Fernández E, Espinosa O, Remigia MJ, Moratalla L, Goterris R, García-Martín P, Ruiz-Cabello F, Garzón S, Pascual MJ, Espigado I, Solano C.
Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study.
Cytotherapy.
Martínez C, Jorge AS, Pereira A, Moreno M, Núñez J, Gayoso J, González-Medina J, Revilla N, Sampol A, Domingo-Domenech E, de la Cruz F, Morales A, Rodríguez-Salazar MJ, Valiente S, Pérez-Ceballos E, de Oteyza JP, García-Sanz R, Hodgkin Lymphoma Subcommittee of Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO).
Comorbidities, not age, are predictive of survival after autologous hematopoietic cell transplantation for relapsed/refractory Hodgkin's lymphoma in patients older than 50 years
Ann Hematol.
Palau J, Sancho E, Herrera M, Sánchez S, Mingot ME, Upegui RI, Rodríguez Salazar MJ, de la Cruz F, Fernández MC, González López TJ, Hernández JJ, Ríos E, López-Fernández MF, García M, Hernández JÁ, Sanz MA.
Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study.
Hematology.
Prats-Martín C, Franco-Macías E, Morales-Camacho RM, Pérez O, Vargas MT, de la Cruz Vicente F, Borrero JJ, Bernal R, Pérez-Simón JA.
Intravascular lymphoma: look through the small vessels
Ann Hematol.